Study maps beta-agonist residue depletion in broiler tissues

A newly published study in Frontiers in Veterinary Science offers updated evidence on how three β-adrenergic agonists behave in broiler chickens, with direct relevance for residue surveillance and food-safety enforcement. The researchers examined salbutamol, clenbuterol, and terbutaline in 168 Ross 308 broilers and found clear differences in how long each compound persisted in edible tissues: terbutaline depleted fastest, clenbuterol lasted longest, and residues were consistently highest in kidney and liver. The article was published September 23, 2026. (frontiersin.org)

The backdrop is longstanding regulatory concern over β-agonist misuse in food-producing animals. EU food-safety rules require member states to run residue-control plans aimed at detecting illegal use or misuse of pharmacologically active substances, and the analytical methods used in those programs are governed by Commission Implementing Regulation (EU) 2021/808. EFSA said in its latest summary of 2024 monitoring data that official compliance remains high overall, but β-agonists remain part of the substances covered by routine surveillance. (food.ec.europa.eu)

In the new study, the compounds were administered through drinking water at 2.5 or 5 mg/L for seven consecutive days. The authors said that design was intended to mimic covert exposure rather than an approved production practice. Residues were measured in breast muscle, liver, and kidney using a validated LC-MS/MS method aligned with EU analytical standards. Quantifiable residues were present in all three tissues at the first post-treatment sampling point, with the strongest signal in kidney and liver and the weakest in breast muscle. By Day 46, all residues were below matrix-specific decision limits, or CCα. (frontiersin.org)

The study also found no growth-promoting benefit under the tested conditions, which undercuts any perceived production rationale for illicit use. That point is notable because β-agonists have historically drawn attention not just for food-safety concerns, but also for their misuse as performance enhancers. The authors reported apparent depletion half-lives in liver of 1.1 to 1.5 days and in kidney of 0.7 to 1.2 days, with clenbuterol showing the longest persistence among the three analytes. (frontiersin.org)

There was also a strong historical echo. A much older PubMed-indexed study examined the same three compounds in treated broiler chickens, suggesting that tissue distribution and withdrawal behavior in poultry have been a concern for decades. The new paper updates that evidence base using current LC-MS/MS methods and an analytical framework designed around modern EU residue-control requirements. That makes the work more actionable for today’s official laboratories and food-safety investigators than older legacy data alone. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinarians working in poultry health, public health, diagnostic labs, or regulatory medicine, this is less about therapeutics and more about detection strategy. The findings support prioritizing liver and kidney when investigating suspected exposure, and they suggest that not all β-agonists should be treated as interchangeable in surveillance programs. A compound that clears quickly, such as terbutaline, may be easier to miss if sampling is delayed, while longer-persisting clenbuterol may widen the detection window. Inference: that could shape both sampling protocols and interpretation of negative findings in enforcement cases. The study also gives veterinarians clearer language for advising producers and pet parents concerned about food safety that residue controls are built around tissue-specific science, not just blanket screening. (frontiersin.org)

Expert reaction specific to this paper was limited at publication, and no separate press release or outside commentary was readily available in the initial coverage I reviewed. Still, the broader industry context points in one direction: residue monitoring is becoming more method-driven, with EU guidance emphasizing validation, comparability, and minimum performance requirements for official laboratories. In that environment, studies like this tend to matter most when they sharpen where labs look, what they test for, and how long after exposure they can reasonably expect to detect a signal. (food.ec.europa.eu)

What to watch: The next step is whether these data move beyond publication into practice — for example, in laboratory reference materials, national residue-control plans, or future reviews of β-agonist monitoring priorities in poultry. If follow-on studies add field-case data or individual-bird variability, that would make the evidence even more useful for real-world enforcement and risk assessment. (food.ec.europa.eu)